Haitian
Scientific Society Seminar
Series
Saturday December 2, 2023
12:45-2:30
Zoom-Link: https://umassboston.zoom.us/j/94777986513
Emerging Treatments for Arthritis: A Clinical Trial
Retrospective
Vladimir Geneus
AbbVie, Inc
Abstract: Ixekizumab is effective in the treatment of radiographic axial spondyloarthritis regardless of the level of C-reactive protein
or magnetic resonance imaging scores: 16-week data from COAST-V and COAST-W.
Biography:
Vladimir
J. Geneus, Ph.D. is a Senior Research Scientist at
AbbVie, Inc. He is the lead statistician for over a dozen concurrent studies
(Phases II-IV) in the specialty therapeutic area. Prior to his position at
AbbVie, Inc., Vladimir served as a Research Scientist at Eli Lilly &
Company, where he led the design of clinical studies and experimental designs
and oversaw ad hoc analyses and disclosures as a medical affairs statistician. Vladimir
has gained statistical experience in various fields throughout his career:
biopharmaceutical (Pfizer, Inc.), government (Florida Department of Education),
and academia (University of Arkansas Medical School). His interests include
nonparametric statistics, design of experiments, and Bayesian designs. Vladimir
earned a Bachelor of Science degree in Mathematics from the University of
Massachusetts, Amherst with, a Master of Science degree in Applied Mathematics
from Northeastern University, and a Doctor of Philosophy degree in Statistics
from Florida State University. Most importantly, Vladimir remains passionate
about helping graduate students, particularly those from marginalized groups,
transition into their post-graduate careers.